Genetic Sequencing for EDS Subtypes

Type: diagnostic

Status: FDA Approved

Developer: Various academic institutions and commercial labs (e.g., Invitae, GeneDx)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026